Attenuated Bordetella pertussis BPZE1 protects against allergic airway inflammation and contact dermatitis in mouse models

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 10, 2012, Pages 1250-1258

  Li, R ^a,f   Cheng, C ^a   Chong, S Z ^a   Lim, A R F ^a   Goh, Y F ^a   Locht, C ^b,c,d,e   Kemeny, D M ^a   Angeli, V ^a   Wong, W S F ^a   Alonso, S ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INSERM   (France)

^c INSERM U1019   (France)

^d UNIV LILLE   (France)

^e INSTITUT PASTEUR DE LILLE   (France)

^f FUDAN UNIVERSITY   (China)

Author keywords

allergic airway inflammation; Bordetella pertussis BPZE1; contact hypersensitivity; inflammatory disease; pro inflammatory cytokines

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; BPZE 1; CYTOKINE; IMMUNOGLOBULIN E; OVALBUMIN; PERTUSSIS VACCINE; UNCLASSIFIED DRUG;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORDETELLA PERTUSSIS; CONTACT DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; INFLAMMATORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SKIN INFLAMMATION;

ADMINISTRATION, INTRANASAL; ANIMALS; BORDETELLA PERTUSSIS; CYTOKINES; DERMATITIS, CONTACT; DINITROCHLOROBENZENE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; OVALBUMIN; PERTUSSIS VACCINE; PNEUMONIA; VACCINES, ATTENUATED; WHOOPING COUGH;

EID: 84866452569     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02884.x     Document Type: Article

References (34)

1. Li R, Lim A, Phoon MC, Narasaraju T, Ng JK, Poh WP, et al. Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm. J Virol 2010; 84: 7105-7113.
2. Galli SJ, Tsai M, Piliponsky AM,. The development of allergic inflammation. Nature 2008; 454: 445-454.
3. Masoli M, Fabian D, Holt S, Beasley R,. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59: 469-478. (Pubitemid 38580764)
4. Kim HY, DeKruyff RH, Umetsu DT,. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol 2010; 11: 577-584.
5. Novak N, Simon D,. Atopic dermatitis-from new pathophysiologic insights to individualized therapy. Allergy 2011; 66: 830-839.
6. Watanabe H, Unger M, Tuvel B, Wang B, Sauder DN,. Contact hypersensitivity: the mechanism of immune responses and T cell balance. J Interferon Cytokine Res 2002; 22: 407-412. (Pubitemid 34579542)
7. Saint-Mezard P, Berard F, Dubois B, Kaiserlian D, Nicolas JF,. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol 2004; 14: 131-138. (Pubitemid 38738449)
8. Strachan DP,. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000; 55 Suppl. 1: S2-S10. (Pubitemid 30468238)
9. Ennis DP, Cassidy JP, Mahon BP,. Prior Bordetella pertussis infection modulates allergen priming and the severity of airway pathology in a murine model of allergic asthma. Clin Exp Allergy 2004; 34: 1488-1497. (Pubitemid 39233707)
10. 2LEN-DARE systematic review. Allergy 2011; 66: 458-468.
11. Lukacs NW, Tekkanat KK, Berlin A, Hogaboam CM, Miller A, Evanoff H, et al. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J Immunol 2001; 167: 1060-1065. (Pubitemid 32660865)
12. Kavanagh H, Noone C, Cahill E, English K, Locht C, Mahon BP,. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model. Clin Exp Allergy 2010; 40: 933-941.
13. Fischer K, Stein K, Ulmer AJ, Lindner B, Heine H, Holst O,. Cytokine-inducing lipoteichoic acids of the allergy-protective bacterium Lactococcus lactis G121 do not activate via Toll-like receptor 2. Glycobiology 2011; 21: 1588-1595.
14. Bieber T, Simon H-U,. Allergen-specific immunotherapy: current concepts and future directions. Allergy 2011; 66: 709-712.
15. Mielcarek N, Debrie AS, Raze D, Bertout J, Rouanet C, Younes AB, et al. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2006; 2: e65.
16. Menozzi FD, Mutombo R, Renauld G, Gantiez C, Hannah JH, Leininger E, et al. Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis. Infect Immun 1994; 62: 769-778. (Pubitemid 24065554)
17. Bao Z, Lim S, Liao W, Lin Y, Thiemermann C, Leung BP, et al. Glycogen synthase kinase-3beta inhibition attenuates asthma in mice. Am J Respir Crit Care Med 2007; 176: 431-438. (Pubitemid 47358096)
18. Duan W, Chan JH, Wong CH, Leung BP, Wong WS,. Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol 2004; 172: 7053-7059. (Pubitemid 38669147)
19. Evans CM, Williams OW, Tuvim MJ, Nigam R, Mixides GP, Blackburn MR, et al. Mucin is produced by clara cells in the proximal airways of antigen-challenged mice. Am J Respir Cell Mol Biol 2004; 31: 382-394. (Pubitemid 39330948)
20. Ennis DP, Cassidy JP, Mahon BP,. Whole-cell pertussis vaccine protects against Bordetella pertussis exacerbation of allergic asthma. Immunol Lett 2005a; 97: 91-100. (Pubitemid 40038859)
21. Ennis DP, Cassidy JP, Mahon BP,. Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model. Clin Diagn Lab Immunol 2005b; 12: 409-417. (Pubitemid 41175336)
22. Feunou PF, Ismaili J, Debrie AS, Huot L, Hot D, Raze D, et al. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1. Vaccine 2008; 26: 5722-5727.
23. Skerry CM, Cassidy JP, English K, Feunou-Feunou P, Locht C, Mahon BP,. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. Clin Vaccine Immunol 2009; 16: 1344-1351.
24. Bao Z, Guan S, Cheng C, Wu S, Wong SH, Kemeny DM, et al. A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kappaB pathway. Am J Respir Crit Care Med 2009; 179: 657-665.
25. Guan SP, Kong LR, Cheng C, Lim JC, Wong WS,. Protective role of 14-deoxy-11,12-didehydroandrographolide, a noncytotoxic analogue of andrographolide, in allergic airway inflammation. J Nat Prod 2011; 74: 1484-1490.
26. Nahori MA, Lagranderie M, Lefort J, Thouron F, Joseph D, Winter N, et al. Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns. Vaccine 2001; 12: 1484-1495. (Pubitemid 32332734)
27. Page KR, Scott AL, Manabe YC,. The expanding realm of heterologous immunity: friend or foe? Cell Microbiol 2006; 8: 185-196. (Pubitemid 43356042)
28. Walzl G, Tafuro S, Moss P, Openshaw PJ, Hussell T,. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. J Exp Med 2000; 192: 1317-1326.
29. Tsitoura DC, Kim S, Dabbagh K, Berry G, Lewis DB, Umetsu DT,. Respiratory infection with influenza A virus interferes with the induction of tolerance to aeroallergens. J Immunol 2000; 165: 3484-3491.
30. Hogan RJ, Zhong W, Usherwood EJ, Cookenham T, Roberts AD, Woodland DL,. Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs. J Exp Med 2001; 193: 981-986. (Pubitemid 32525871)
31. de Bree GJ, van Leeuwen EM, Out TA, Jansen HM, Jonkers RE, van Lier RA,. Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. J Exp Med 2005; 202: 1433-1442. (Pubitemid 41668745)
32. Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB,. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004; 5: 337-343. (Pubitemid 38332131)
33. Beyer M, Bartz H, Horner K, Doths S, Koerner-Rettberg C, Schwarze J,. Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection. J Allergy Clin Immunol 2004; 113: 127-133. (Pubitemid 38096172)
34. Didierlaurent A, Goulding J, Patel S, Snelgrove R, Low L, Bebien M, et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med 2008; 205: 323-329. (Pubitemid 351281598)